SMTI
Sanara Medtech
$25.85
+$0.29 (+1.13%)Jul 27, 2026
Key metrics
The numbers that frame SMTI today
- Market cap
- $236.89M
- P/E (TTM)
- -7.1
- EV / FCF
- 80.5
- Gross margin
- 92.9%
- EV / Sales
- 2.5
- ROIC
- -40.2%
- Div yield
- 0%
- Debt / equity
- 6.9
- 52wk Low
- $16.05
- 52wk High
- $35.95
Growth
Revenue and earnings trend for SMTI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SMTI
Is Sanara Medtech a good buy?
Yes. Sanara Medtech has excellent quality and mixed momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Sanara Medtech is selling at a high price, which cuts against the buy case.
What is the market capitalization of SMTI?
Sanara Medtech's market capitalization is $236.89M.
What is the P/E ratio for SMTI stock?
Sanara Medtech's current P/E ratio is -7.1.
What is the 52-week high for SMTI stock?
The 52-week high for Sanara Medtech is $35.95. The current close of $25.85 is 28.1% below that high.
What is the 52-week low for SMTI stock?
The 52-week low for Sanara Medtech is $16.05. The current close of $25.85 is 61.1% above that low.
Does SMTI stock pay dividends?
Sanara Medtech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SMTI?
Sanara Medtech's Debt / Equity ratio is 6.88.